home / stock / xlrn / xlrn message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: XLRN 5% v1.2M c90.78 F53M gap up four days ago with big vol and maintained the S@$78 with | znewcar1 | investorshangout | 02/03/2020 4:04:55 AM |
$XLRN: NEWS........ 60% POPPER Sotatercept | makinezmoney | investorshub | 01/28/2020 12:20:41 PM |
Shares of Acceleron Pharma Inc. ($XLRN) are moving | crudeoil24 | investorshub | 11/08/2019 7:21:43 PM |
Heard we got news today | PennyStock Alert | investorshub | 09/17/2019 3:36:51 PM |
This company has good products but has a | faxedreceipts | investorshub | 07/27/2018 9:29:31 PM |
Looks like this is already trading like everything | PennyPicksPro | investorshub | 07/02/2018 3:40:19 AM |
XLRN buy 48.52 | stocktrademan | investorshub | 07/02/2018 2:21:31 AM |
Looking good here | goodfree | investorshub | 03/15/2018 3:10:46 PM |
$XLRN recent news/filings | stocktrademan | investorshub | 12/18/2015 8:15:20 PM |
Acceleron and Celgene Announce Interim Clinical Data for | Gixene | investorshub | 04/25/2014 9:00:07 PM |
7:01AM Acceleron Pharma earns $7 mln milestone payment | surf1944 | investorshub | 12/18/2013 2:45:28 PM |
New board. | Gixene | investorshub | 10/30/2013 8:45:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Acceleron Pharma Inc. Company Name:
XLRN Stock Symbol:
NASDAQ Market:
Acceleron Pharma Inc. Website:
Believes Transaction Comes at the Wrong Time, With the Wrong Price, and Following the Wrong Process Remains Confident in Company’s Standalone Opportunities – Given Strong Momentum and Near-Term Inflection Point Coming from Phase 3 Data Stands Ready to Hel...
In September, Merck (NYSE: MRK) announced plans to acquire Acceleron Pharma (NASDAQ: XLRN) for $11.5 billion. However, the big drugmaker recently revealed that it withdrew a key regulatory filing document related to the transaction. In this Motley Fool Live video ...